These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9374926

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.
    Hobbs RN, Clayton AL, Bernstein RM.
    Ann Rheum Dis; 1987 May; 46(5):408-16. PubMed ID: 2884934
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Left-handed "Z" DNA antibodies in rheumatoid arthritis and systemic lupus erythematosus.
    Sibley JT, Lee JS, Decoteau WE.
    J Rheumatol; 1984 Oct; 11(5):633-7. PubMed ID: 6334742
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
    Walker EM, Carty JE.
    Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
    [Abstract] [Full Text] [Related]

  • 31. The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus.
    Permin H, Wiik A.
    Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):245-9. PubMed ID: 309705
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment.
    Wildhagen K, Hartung K, Hammer M, Mau W, Schmidt RE, Deicher H, Zeidler H.
    Clin Rheumatol; 1993 Jun; 12(2):265-7. PubMed ID: 8102951
    [Abstract] [Full Text] [Related]

  • 34. [Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers].
    Specker C, Lakomek HJ, Kuntz BM, Bremer G, Goerz G, Krüskemper HL.
    Dtsch Med Wochenschr; 1987 Apr 10; 112(15):577-80. PubMed ID: 3493893
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
    Rauch J, Massicotte H, Tannenbaum H.
    J Immunol; 1985 Oct 10; 135(4):2385-92. PubMed ID: 3875652
    [Abstract] [Full Text] [Related]

  • 39. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
    Batchelor JR, Welsh KI, Tinoco RM, Dollery CT, Hughes GR, Bernstein R, Ryan P, Naish PF, Aber GM, Bing RF, Russell GI.
    Lancet; 1980 May 24; 1(8178):1107-9. PubMed ID: 6103441
    [Abstract] [Full Text] [Related]

  • 40. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease.
    Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M.
    Arthritis Rheum; 1989 Jul 24; 32(7):826-36. PubMed ID: 2787639
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.